Production (Stage)
Tiziana Life Sciences Ltd
TLSA
$1.58
$0.2115.33%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -3.60M | -3.60M | -2.33M | -2.33M | -4.54M |
| Total Depreciation and Amortization | 31.00K | 31.00K | 31.00K | 31.00K | 20.50K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 3.73M | 3.73M | 1.65M | 1.65M | 560.50K |
| Change in Net Operating Assets | -1.12M | -1.12M | 842.00K | 842.00K | 1.80M |
| Cash from Operations | -963.00K | -963.00K | 200.00K | 200.00K | -2.15M |
| Capital Expenditure | -2.50K | -2.50K | -7.00K | -7.00K | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -500.00K |
| Cash from Investing | -2.50K | -2.50K | -7.00K | -7.00K | -500.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -36.00K | -36.00K | -34.50K | -34.50K | -41.00K |
| Issuance of Common Stock | 2.32M | 2.32M | -- | -- | 12.50K |
| Repurchase of Common Stock | -26.00K | -26.00K | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | 67.50K |
| Cash from Financing | 2.26M | 2.26M | -34.50K | -34.50K | 39.00K |
| Foreign Exchange rate Adjustments | 1.50K | 1.50K | -185.00K | -185.00K | -93.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.30M | 1.30M | -26.50K | -26.50K | -2.71M |